Insider Buying: Clorox (NYSE:CLX) Director Purchases 5,000 Shares of Stock

Key Points

• Pierre Breber, a Clorox director, bought 5,000 shares on May 5 at an average price of $85.82 (≈$429,100), increasing his stake to 18,000 shares (a 38.46% rise) with the purchase disclosed in an SEC filing.
• Clorox beat quarterly EPS estimates with $1.64 per share, set FY2026 guidance of $5.45–$5.65 EPS, and announced a quarterly dividend of $1.24 (annualized yield ~5.8% and DPR ~80.5%).
• The stock is trading near $86 (12‑month range $84.70–$138.94) while analysts hold a consensus "Reduce" rating with a $104 target, reflecting mixed views (1 Buy, 12 Hold, 4 Sell).

The Clorox Company (NYSE:CLX - Get Free Report) Director Pierre Breber purchased 5,000 shares of the company's stock in a transaction dated Tuesday, May 5th. The stock was purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares in the company, valued at $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Clorox Price Performance

Shares of CLX traded down $0.31 during trading hours on Tuesday, reaching $86.17. The stock had a trading volume of 3,678,407 shares, compared to its average volume of 2,503,507. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $138.94. The stock has a market capitalization of $10.42 billion, a PE ratio of 13.99, a PEG ratio of 0.46 and a beta of 0.59. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The company's 50-day moving average is $108.21 and its two-hundred day moving average is $108.66.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts' consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.67 billion. During the same period in the prior year, the company earned $1.45 EPS. Clorox's revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Research analysts expect that The Clorox Company will post 5.56 EPS for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Wednesday, April 22nd will be given a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a yield of 5.8%. The ex-dividend date of this dividend is Wednesday, April 22nd. Clorox's dividend payout ratio (DPR) is currently 80.52%.

Institutional Trading of Clorox

A number of large investors have recently bought and sold shares of the business. Haverford Trust Co grew its holdings in Clorox by 2.8% during the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company's stock worth $310,000 after acquiring an additional 84 shares during the period. Field & Main Bank grew its holdings in Clorox by 3.3% during the 4th quarter. Field & Main Bank now owns 3,100 shares of the company's stock worth $313,000 after acquiring an additional 100 shares during the period. Golden State Wealth Management LLC grew its holdings in Clorox by 28.2% during the 4th quarter. Golden State Wealth Management LLC now owns 454 shares of the company's stock worth $46,000 after acquiring an additional 100 shares during the period. Fisher Asset Management LLC grew its holdings in Clorox by 1.7% during the 3rd quarter. Fisher Asset Management LLC now owns 6,053 shares of the company's stock worth $746,000 after acquiring an additional 102 shares during the period. Finally, Kestra Private Wealth Services LLC grew its holdings in Clorox by 1.8% during the 1st quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company's stock worth $617,000 after acquiring an additional 104 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. Wells Fargo & Company lowered their target price on Clorox from $110.00 to $100.00 and set an "equal weight" rating for the company in a research report on Friday. The Goldman Sachs Group reaffirmed a "sell" rating and set a $83.00 target price on shares of Clorox in a research report on Friday. TD Cowen raised their target price on Clorox from $98.00 to $111.00 and gave the stock a "hold" rating in a research report on Tuesday, March 31st. Royal Bank Of Canada lowered their target price on Clorox from $132.00 to $127.00 and set a "sector perform" rating for the company in a research report on Thursday, April 9th. Finally, Rothschild & Co Redburn set a $117.00 target price on Clorox in a research report on Friday, February 13th. One research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Reduce" and a consensus target price of $104.00.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.